(19)
(11) EP 1 578 903 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
14.03.2012 Bulletin 2012/11

(45) Mention of the grant of the patent:
23.11.2011 Bulletin 2011/47

(21) Application number: 02762148.1

(22) Date of filing: 17.04.2002
(51) International Patent Classification (IPC): 
C12N 15/00(2006.01)
C12N 15/09(2006.01)
C12N 15/70(2006.01)
C12P 21/04(2006.01)
C12Q 1/70(2006.01)
C12P 21/06(2006.01)
C12N 15/63(2006.01)
C12N 15/74(2006.01)
C12Q 3/00(2006.01)
G01N 33/53(2006.01)
(86) International application number:
PCT/US2002/012405
(87) International publication number:
WO 2002/083872 (24.10.2002 Gazette 2002/43)

(54)

NOVEL METHODS OF CONSTRUCTING LIBRARIES COMPRISING DISPLAYED AND/OR EXPRESSED MEMBERS OF A DIVERSE FAMILY OF PEPTIDES, POLYPEPTIDES OR PROTEINS AND THE NOVEL LIBRARIES

NEUE VERFAHREN ZUM AUFBAU VON PRÄSENTIERTEN UND/ODER EXPRIMIERTEN MITGLIEDERN EINER WEITLÄUFIGEN FAMILIE VON PEPTIDEN, POLYPEPTIDEN ODER PROTEINEN UMFASSENDEN BIBLIOTHEKEN SOWIE DIE NEUEN BIBLIOTHEKEN

NOUVEAUX PROCEDES DE CONSTRUCTION DE BIBLIOTHEQUES COMPRENANT DES MEMBRES VISUALISES ET/OU EXPRIMES DE DIVERSES FAMILLES DE PEPTIDES, POLYPEPTIDES ET PROTEINES ET NOUVELLES BIBLIOTHEQUES OBTENUES


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 17.04.2001 US 837306
24.10.2001 US 516
25.10.2001 US 45674

(43) Date of publication of application:
28.09.2005 Bulletin 2005/39

(73) Proprietor: Dyax Corp.
Cambridge, MA 02139 (US)

(72) Inventors:
  • LADNER, Robert C.
    Ijamsville, MD 21754 (US)
  • COHEN, Edward H.
    Belmont, MA 02478 (US)
  • NASTRI, Horacio G.
    Needham, MA 02492 (US)
  • ROOKEY, Kristin L.
    Revere, MA 02151 (US)
  • HOET, René
    6226 CZ Maastricht (NL)
  • HOOGENBOOM, Hendricus R.J.M.
    6214 AE Maastricht (NL)

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)


(56) References cited: : 
DE-A1- 19 624 562
US-A- 5 380 833
US-A- 5 798 208
US-A- 5 858 671
US-A- 5 223 409
US-A- 5 688 666
US-A- 5 846 765
US-A- 5 969 108
   
  • DAVIES J ET AL: "Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding" IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 3, September 1996 (1996-09), pages 169-179, XP004070292 ISSN: 1380-2933
  • ARDEN B: "Conserved motifs in T-cell receptor CDR1 and CDR2: implications for ligand and CD8 co-receptor binding" CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, vol. 10, no. 1, February 1998 (1998-02), pages 74-81, XP004313624 ISSN: 0952-7915
  • HOOGENBOOM H R ET AL: "By-passing Immunisation - Human Antibodies from Synthetic Repertoires of Germline VH Gene Segments Rearranged in Vitro" JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 227, 1992, pages 381-388, XP002974448 ISSN: 0022-2836
  • DE HAARD H J ET AL: "A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 274, no. 26, 25 June 1999 (1999-06-25), pages 18218-18230, XP002128301 ISSN: 0021-9258
  • TOMLINSON I M ET AL: "THE REPERTOIRE OF HUMAN GERMLINE VH SEQUENCES REVEALS ABOUT FIFTY GROUPS OF VH SEGMENTS WITH DIFFERENT HYPERVARIABLE LOOPS" JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 227, 1992, pages 776-798, XP000990787 ISSN: 0022-2836
  • BARBAS S M ET AL: "HUMAN AUTOANTIBODY RECOGNITION OF DNA" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 92, March 1995 (1995-03), pages 2529-2533, XP002927212 ISSN: 0027-8424
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).